Shares in Hikma Pharmaceuticals (HIK) tumbled 16% after the company posted a disappointing FY26 sales and profit outlook. The FTSE 100 stock dropped to £13.87 on the update, its lowest level in more than three years. Share price: £13.87 (-16%) PE: 11.1x Market cap: £3bn Yield: 3.6% Guidance disappoints The company, which makes treatments for … Continue reading Hikma tumbles on disappointing outlook